Caspase-11–mediated hyperinflammation impairs CD8+ T cell immunity and viral clearance in severe SARS-CoV-2 infection
JCI Insight · 2026
DOI: 10.1172/jci.insight.199896 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2026. Verfasst von Mostafa M Eltobgy und 34 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Caspases, Caspases, Initiator, CD8-Positive T-Lymphocytes, COVID-19. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, NIDA NIH HHS.
Abstract (Originalsprache)
Severe SARS-CoV-2 infection is characterized by lung hyperinflammation, impaired IFN responses, and defective T cell activation, yet the molecular drivers of these immune dysregulations remain incompletely understood. Caspase-11 (CASP11), a key effector of the noncanonical inflammasome, has been shown to mediate an innate hyperinflammatory response and cytokine release in a mild SARS-CoV-2 infection model. However, the role played by CASP11 in severe SARS-CoV-2 disease and how it affects adaptive immunity has not been identified. Here, we found that CASP11 exacerbates severe SARS-CoV-2 pathogenesis by amplifying early innate immune responses while concurrently impairing antiviral CD8 + T cell immunity. Using global KO mice, hematopoietic BM chimeras, and Cx3cr1-expressing mononuclear phagocyte system cell–specific CASP11 deletion models, we show that targeting CASP11 reduces lung inflammation, promotes early NK cell–mediated IFN-γ production, and enhances robust virus-specific effector CD8 + T cell responses. This was associated with enhanced viral clearance and improved survival, even under lethal infection conditions. Importantly, CASP11-KO mice also exhibited faster resolution of postviral inflammation. These findings position CASP11 as a promising immunomodulatory target for acute and delayed manifestations of severe SARS-CoV-2 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, Ohio, USA.
- Department of Microbiology and Immunology, Faculty of Pharmacy, Helwan University, Cairo, Egypt.
- Department of Neurology, College of Medicine and Wexner Medical Center.
- Neuroscience Research Institute, and.
- Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio, USA.
- College of Nursing, University of South Florida, Tampa, Florida, USA.
Förderung
- NHLBI NIH HHS
- NIAID NIH HHS
- NIDA NIH HHS
- NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Eltobgy, M. M., Shamseldin, M. M., Whitham, O. D., Amer, H. M., Atkinson, J. R., Badr, A., Hall, J. M., Gupta, G., Hassan, Y. Y., El-Mergawy, R., Perez, R., Faber, S. E., Pietrzak, M., Webb, A., Zhang, X., Kenney, A. D., Bissell, D., Omran, J. I., Estfanous, S., …, & Amer, A. O. (2026). Caspase-11–mediated hyperinflammation impairs CD8+ T cell immunity and viral clearance in severe SARS-CoV-2 infection. JCI Insight. https://doi.org/10.1172/jci.insight.199896
Vancouver
Eltobgy MM, Shamseldin MM, Whitham OD, Amer HM, Atkinson JR, Badr A, et al. Caspase-11–mediated hyperinflammation impairs CD8+ T cell immunity and viral clearance in severe SARS-CoV-2 infection. JCI Insight. 2026. doi:10.1172/jci.insight.199896
BibTeX
@article{Eltobgy2026,
author = {Eltobgy, Mostafa M and Shamseldin, Mohamed M and Whitham, Owen D and Amer, Heba M and Atkinson, Jeffrey R and Badr, Asmaa and Hall, Jesse M and Gupta, Gauruv and Hassan, Yara Y and El-Mergawy, Rabab and Perez, Richard and Faber, Sarah E and Pietrzak, Maciej and Webb, Amy and Zhang, Xiaoli and Kenney, Adam D and Bissell, Destiny and Omran, Jihad I and Estfanous, Shady and Daily, Kylene P and Yousif, Amir and Joldrichsen, Marisa R and McNamara, Andrew and Kc, Mahesh and Peeples, Mark E and Hemann, Emily A and Ghoneim, Hazem E and Nimjee, Shahid M and Cormet-Boyaka, Estelle and Li, Jianrong and Boyaka, Prosper N and Yount, Jacob S and Segal, Benjamin M and Dubey, Purnima and Amer, Amal O},
title = {Caspase-11–mediated hyperinflammation impairs CD8+ T cell immunity and viral clearance in severe SARS-CoV-2 infection},
journal = {JCI Insight},
year = {2026},
doi = {10.1172/jci.insight.199896}
}
EUVIMED